Latest Regulatory News

Steadfast Group Limited has updated its dividend announcement, confirming a fully franked dividend of AUD 0.117 per share and setting the Dividend Reinvestment Plan price at AUD 5.982 with a 2.5% discount.

Northern Star Resources reaffirms its Ore Reserves and Mineral Resources as of March 2025, maintaining steady production targets and a robust balance sheet while advancing key growth projects including the KCGM Mill Expansion and the Hemi Development Project.

Downer EDI Limited has announced its key shareholder dates for 2025, including the Annual General Meeting scheduled for November 11 and the final dividend payment on October 2. These dates mark important milestones for investors in one of Australia and New Zealand's leading infrastructure service providers.

Blue Energy Limited has addressed ASX concerns over the timing of its Cleansing Notice related to the grant of Production Licence PL 1034 for its Sapphire gas project, confirming compliance with disclosure rules despite delayed formal notification.

Marvel Gold Limited has significantly increased its landholding in Tanzania’s Iramba-Sekenke Greenstone Belt, acquiring two new prospecting licences and applying for a third, setting the stage for a maiden drilling campaign.

Celsius Resources has reported significant high-grade copper and gold drilling results at its MCB Project in the Philippines, alongside securing a conditional water permit crucial for advancing project development.

The Takeovers Panel has declined to declare unacceptable circumstances in Bryah Resources' shareholder dispute but has referred key issues to ASIC for further investigation.

Northern Minerals has released its Definitive Feasibility Study for the Browns Range Heavy Rare Earth Project, confirming an 11-year production plan targeting 181,000 tonnes of rare earth concentrate. The project aims to establish a critical Australian supply chain for heavy rare earths in partnership with Iluka Resources.

Artrya Limited has completed the first tranche of its A$75 million placement, raising approximately A$60 million to advance its AI-driven coronary artery disease platform. Eligible shareholders can now participate in a Share Purchase Plan at the same price.

Carbonxt Group has successfully closed its non-renounceable pro-rata entitlement offer, issuing over 51 million Loyalty Options and raising approximately $514,000 to support its expansion plans.

Cleo Diagnostics has received encouraging feedback from the U.S. FDA on its ovarian cancer pre-surgical triage test, reinforcing its clinical trial design and regulatory strategy ahead of a critical 510(k) submission.

TMK Energy Limited’s securities have been suspended from ASX trading due to a missed periodic report deadline, raising questions about the company’s regulatory adherence and market outlook.